Figure S6 from HER3 Augmentation Via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer
crossref(2023)
Abstract
Box-and-whisker plot of ZEB1/2, Twist1, and SNAI1/2 mRNA expression in pretreatment and posttreatment samples from all tumors and in subpopulations with HER3 augmentation.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined